Alembic Pharmaceuticals Profit & Loss Annual

Trade
BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | Sector: Biotechnology & Drugs
953.80 -6.90 (-0.72%)Updated : 24 May 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 6,228.635,652.625,305.795,393.13
Total Revenue 6,228.635,652.625,305.795,393.13
Costof Revenue Total 1,715.082,174.701,844.031,639.99
Gross Profit 4,513.553,477.923,461.763,753.14
Selling/ General/ Admin Expenses Total 1,446.292,178.211,945.861,745.86
Depreciation/ Amortization 272.67275.43286.78183.47
Other Operating Expenses Total 2,133.9117.5512.678.41
Total Operating Expense 5,567.955,214.824,718.334,096.30
Operating Income 660.68437.80587.461,296.83
Interest Inc( Exp) Net- Non- Op Total -561.90-491.80311.80691.20
Other Net 28.311.580.930.74
Net Income Before Taxes 632.80385.50620.111,368.08
Provisionfor Income Taxes 16.0012.61104.46253.32
Net Income After Taxes 616.80372.89515.651,114.76
Equity In Affiliates -9.80-309.2052.80317.40
Net Income Before Extra Items 615.82341.97520.931,146.50
Net Income 615.82341.97520.931,146.50
Income Availableto Com Excl Extra Ord 615.82341.99520.941,146.50
Income Availableto Com Incl Extra Ord 615.82341.99520.941,146.50
Diluted Net Income 615.82341.99520.941,146.50
Diluted Weighted Average Shares 19.6619.6619.6619.37
Diluted EPS Excluding Extra Ord Items 31.3317.4026.5059.18
DPS- Common Stock Primary Issue 11.008.0010.0014.00
Diluted Normalized EPS 31.3317.6326.4859.12
Research Development -5,689.306,289.905,185.70
Unusual Expense( Income) -0.00--
Gain( Loss)on Saleof Assets --47.005.4013.90
Total Adjustmentsto Net Income -0.200.10-
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,516.65+24.45(1.64%)
1,389.40+15.45(1.12%)
3,625.95+39.80(1.11%)
2,867.40-35.05 (-1.21%)
1,321.90-15.80 (-1.18%)
HomeMarketsPremiumFor youGet App